We are live on
!
Find out more
HA
Harfst & Associates Portfolio holdings
AUM
$643M
1-Year Est. Return
24.12%
This Fund
S&P 500
This Quarter
Est. Return
-5.36%
1 Year Est. Return
+24.12%
3 Year Est. Return
+82.48%
5 Year Est. Return
+108.64%
10 Year Est. Return
+384.36%
AUM
$154M
AUM Growth
-$91.7M
(-37%)
Cap. Flow
-$80.2M
Cap. Flow
% of AUM
-52.06%
Top 10 Holdings %
Top 10 Hldgs %
82.82%
Holding
301
New
2
Increased
19
Reduced
43
Closed
230
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$994K |
| 2 |
Vanguard Intermediate-Term Bond ETF
BIV
|
+$671K |
| 3 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$473K |
| 4 |
Chubb
CB
|
+$401K |
| 5 |
Invesco S&P 500 Low Volatility ETF
SPLV
|
+$288K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hormel Foods
HRL
|
+$2.61M |
| 2 |
Eli Lilly
LLY
|
+$2.5M |
| 3 |
Stryker
SYK
|
+$2.04M |
| 4 |
Microsoft
MSFT
|
+$2.02M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 40.42% |
| 2 | Consumer Staples | 6.32% |
| 3 | Healthcare | 1.72% |
| 4 | Technology | 1.66% |
| 5 | Consumer Discretionary | 1.6% |
Similar funds
CRCM
PCM
GECH
APC
RR
WHGAM
SFG
SCP
Harfst & Associates's Q1 2016 Portfolio in Review
As of Q1 2016, Harfst & Associates held 301 positions worth $154M, down 37% from $246M the previous quarter. Its ten largest holdings account for 83% of the portfolio.
Harfst & Associates withdrew a net $80.2M in Q1 2016, closing 230 positions and reducing 43 holdings. Its most notable exit was Eli Lilly, an estimated $2.5M position sold in full.
By sector, the portfolio is most concentrated in Financials at 40% of assets, up from 33% a quarter earlier, followed by Consumer Staples and Healthcare.
Against the trend, Harfst & Associates opened a new position in Chubb worth $416K.
- Harfst & Associates's largest Q1 2016 buy was Chubb: 3,492 shares worth $416K.
- Harfst & Associates added most to iShares MSCI USA Momentum Factor ETF in Q1 2016, an estimated $994K increase.
- Harfst & Associates's biggest Q1 2016 reduction was Hormel Foods, cutting an estimated $2.61M.
- Harfst & Associates fully exited Eli Lilly in Q1 2016, selling an estimated $2.5M.
- Harfst & Associates's ten largest holdings make up 83% of its $154M portfolio in Q1 2016.
- Harfst & Associates opened 2 new positions and closed 230 in Q1 2016.
- Harfst & Associates's portfolio value fell 37% quarter-over-quarter to $154M.
Based on Harfst & Associates's 13F filing for Q1 2016, filed 3 May 2016.